Senior insider sale
Chief Business Officer at JANUX THERAPEUTICS, INC. — senior position signals high conviction
$455.8K
16.66K shares
What this filing means
MEYER ANDREW HOLLMAN plans to sell 16.66K shares of JANUX THERAPEUTICS, INC. valued at approximately $455.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/28/2025ACC: 0001950047-25-008226
Officer· Chief Business Officer
Since Jun 2021
16.66K
Shares to sell
$455.8K
Approx. market value
16.66K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
10/28/2025
16.66KTotal acquired16.66K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/28/2025 | Exercise of Stock Options Cash | 16.66K | — |
| Total | 16.66K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
16.66K
Market value
$455.8K
10/28/2025
Total
Units
16.66K
Value
$455.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/28/2025 | 16.66K | $455.8K | NASDAQ | Planned |
| Total | 16.66K | $455.8K | ||